front |1 |2 |3 |4 |5 |6 |7 |8 |9 |10 |11 |12 |13 |14 |15 |16 |17 |18 |19 |20 |21 |22 |23 |24 |25 |26 |27 |28 |29 |30 |31 |32 |33 |34 |35 |36 |37 |38 |39 |40 |41 |42 |43 |review |
To determine if there is an additive effect
between the mutation and exposure to OCP, the equation illustrated in slide
12 was used with the data from slide 22. Clearly, there is not an additive
effect between the Factor V Leiden mutation and OCP use in terms of
increasing risk of VT. There may be interaction if the multiplicative model
is also rejected. |